A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
Endometrial Cancer (EC) is one of the most common gynecological malignancies, ranking first in developed countries and regions. The occurrence and development of EC is closely associated with genetic mutations. TP53 mutation, in particular, can lead to the dysfunction of numerous regulatory factors...
Saved in:
Main Authors: | Bohao Zhang, Haozhe Zhang, Yanru Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2025-01-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL25447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01) -
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
by: Yan-Hua Zheng, et al.
Published: (2021-07-01) -
TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate
by: Paula Rofes, et al.
Published: (2025-01-01) -
Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer
by: Zihua Zou, et al.
Published: (2025-01-01) -
To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma
by: Anuja Yadav, et al.
Published: (2023-07-01)